These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 12618385)

  • 1. An analysis of why highly similar enzymes evolve differently.
    Majiduddin FK; Palzkill T
    Genetics; 2003 Feb; 163(2):457-66. PubMed ID: 12618385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of ceftazidime/avibactam against isogenic strains of Escherichia coli containing KPC and SHV β-lactamases with single amino acid substitutions in the Ω-loop.
    Winkler ML; Papp-Wallace KM; Bonomo RA
    J Antimicrob Chemother; 2015 Aug; 70(8):2279-86. PubMed ID: 25957381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SHV-type beta-lactamases.
    Tzouvelekis LS; Bonomo RA
    Curr Pharm Des; 1999 Nov; 5(11):847-64. PubMed ID: 10539992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolution and spread of SHV extended-spectrum beta-lactamases in gram-negative bacteria.
    Heritage J; M'Zali FH; Gascoyne-Binzi D; Hawkey PM
    J Antimicrob Chemother; 1999 Sep; 44(3):309-18. PubMed ID: 10511397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selection and characterization of amino acid substitutions at residues 237-240 of TEM-1 beta-lactamase with altered substrate specificity for aztreonam and ceftazidime.
    Cantu C; Huang W; Palzkill T
    J Biol Chem; 1996 Sep; 271(37):22538-45. PubMed ID: 8798421
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Barnes MD; Winkler ML; Taracila MA; Page MG; Desarbre E; Kreiswirth BN; Shields RK; Nguyen MH; Clancy C; Spellberg B; Papp-Wallace KM; Bonomo RA
    mBio; 2017 Oct; 8(5):. PubMed ID: 29089425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural and Mechanistic Basis for Extended-Spectrum Drug-Resistance Mutations in Altering the Specificity of TEM, CTX-M, and KPC β-lactamases.
    Palzkill T
    Front Mol Biosci; 2018; 5():16. PubMed ID: 29527530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variants of β-lactamase KPC-2 that are resistant to inhibition by avibactam.
    Papp-Wallace KM; Winkler ML; Taracila MA; Bonomo RA
    Antimicrob Agents Chemother; 2015 Jul; 59(7):3710-7. PubMed ID: 25666153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amino acid substitutions causing inhibitor resistance in TEM beta-lactamases compromise the extended-spectrum phenotype in SHV extended-spectrum beta-lactamases.
    Randegger CC; Hächler H
    J Antimicrob Chemother; 2001 May; 47(5):547-54. PubMed ID: 11328764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspartic acid for asparagine substitution at position 276 reduces susceptibility to mechanism-based inhibitors in SHV-1 and SHV-5 beta-lactamases.
    Giakkoupi P; Tzelepi E; Legakis NJ; Tzouvelekis LS
    J Antimicrob Chemother; 1999 Jan; 43(1):23-9. PubMed ID: 10381097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Why the extended-spectrum beta-lactamases SHV-2 and SHV-5 are "hypersusceptible" to mechanism-based inhibitors.
    Kalp M; Bethel CR; Bonomo RA; Carey PR
    Biochemistry; 2009 Oct; 48(41):9912-20. PubMed ID: 19736945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular genetics of resistance to both ceftazidime and beta-lactam-beta-lactamase inhibitor combinations in Klebsiella pneumoniae and in vivo response to beta-lactam therapy.
    Rice LB; Carias LL; Bonomo RA; Shlaes DM
    J Infect Dis; 1996 Jan; 173(1):151-8. PubMed ID: 8537652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Asp104 in the SHV beta-lactamase.
    Bethel CR; Hujer AM; Hujer KM; Thomson JM; Ruszczycky MW; Anderson VE; Pusztai-Carey M; Taracila M; Helfand MS; Bonomo RA
    Antimicrob Agents Chemother; 2006 Dec; 50(12):4124-31. PubMed ID: 16982784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atomic resolution structures of CTX-M beta-lactamases: extended spectrum activities from increased mobility and decreased stability.
    Chen Y; Delmas J; Sirot J; Shoichet B; Bonnet R
    J Mol Biol; 2005 Apr; 348(2):349-62. PubMed ID: 15811373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SHV-129: A Gateway to Global Suppressors in the SHV β-Lactamase Family?
    Winkler ML; Bonomo RA
    Mol Biol Evol; 2016 Feb; 33(2):429-41. PubMed ID: 26531195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overcoming resistance to beta-lactamase inhibitors: comparing sulbactam to novel inhibitors against clavulanate resistant SHV enzymes with substitutions at Ambler position 244.
    Thomson JM; Distler AM; Bonomo RA
    Biochemistry; 2007 Oct; 46(40):11361-8. PubMed ID: 17848099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic effects of functionally distinct substitutions in β-lactamase variants shed light on the evolution of bacterial drug resistance.
    Patel MP; Hu L; Brown CA; Sun Z; Adamski CJ; Stojanoski V; Sankaran B; Prasad BVV; Palzkill T
    J Biol Chem; 2018 Nov; 293(46):17971-17984. PubMed ID: 30275013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probing active site chemistry in SHV beta-lactamase variants at Ambler position 244. Understanding unique properties of inhibitor resistance.
    Thomson JM; Distler AM; Prati F; Bonomo RA
    J Biol Chem; 2006 Sep; 281(36):26734-44. PubMed ID: 16803899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic mutagenesis of the active site omega loop of TEM-1 beta-lactamase.
    Petrosino JF; Palzkill T
    J Bacteriol; 1996 Apr; 178(7):1821-8. PubMed ID: 8606154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ceftazidime-resistant Enterobacteriaceae isolates from three Polish hospitals: identification of three novel TEM- and SHV-5-type extended-spectrum beta-lactamases.
    Gniadkowski M; Schneider I; Jungwirth R; Hryniewicz W; Bauernfeind A
    Antimicrob Agents Chemother; 1998 Mar; 42(3):514-20. PubMed ID: 9517925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.